Anteotech Ltd
ASX:ADO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.018
0.041
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Anteotech Ltd
Anteotech Ltd
Operating Income
Anteotech Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Anteotech Ltd
ASX:ADO
|
Operating Income
-AU$12.7m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-10%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Operating Income
-AU$6.5m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Operating Income
AU$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Operating Income
AU$2.1m
|
CAGR 3-Years
19%
|
CAGR 5-Years
117%
|
CAGR 10-Years
12%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Operating Income
-AU$17.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Operating Income
AU$12.1m
|
CAGR 3-Years
49%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
Anteotech Ltd
Glance View
AnteoTech Ltd. is a global nano-technology company, which develops, manufactures, and distributes products for the life sciences, clinical diagnostics and bio-separations markets. The company is headquartered in Eight Mile Plains, Queensland. The company went IPO on 2000-04-11. The firm is focused on the development and commercialization of its intellectual property of specialized surfaces used in the life sciences, diagnostics, energy and medical devices markets. The firm's products include AnteoCoat, AnteoBind and AnteoRelease, which are used in the energy, diagnostic and medical device markets. The firm's AnteoBind is an aqueous nanosized molecular glue (polymeric metal ions) used in a single-step process to facilitate multivalent coordination to bind carbohydrate polymers, antibodies, and proteins to synthetic substrates in assay development. The firm is also developing, SARS-CoV-2 Ag rapid test, which is a single-use, disposable, lateral flow test for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in nasopharyngeal specimens collected from individuals who are suspected of COVID-19 infection.
See Also
What is Anteotech Ltd's Operating Income?
Operating Income
-12.7m
AUD
Based on the financial report for Jun 30, 2024, Anteotech Ltd's Operating Income amounts to -12.7m AUD.
What is Anteotech Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-10%
Over the last year, the Operating Income growth was 5%. The average annual Operating Income growth rates for Anteotech Ltd have been -18% over the past three years , -30% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
